http://www.bing.com:80/search?q=Pereodic+Table+by+Khan+SirSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Pereodic+Table+by+Khan+SirCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://ispd.org/guidelines/Access comprehensive, evidence-based guidelines and educational materials developed by leading experts in peritoneal dialysis. These resources are designed to improve patient care and outcomes worldwide.Fri, 04 Sep 2026 21:11:00 GMThttps://ispd.org/wp-content/uploads/2025/09/LI-ET-1.pdfThe ISPD 2022 updated recommendations have revised and clarified definitions for refractory peritonitis, relapsing peritonitis, peritonitis-associated catheter removal, PD-associated haemodialysis transfer, peritonitis-associated death and peritonitis-associated hospitalisation.Fri, 04 Sep 2026 12:07:00 GMThttps://journals.sagepub.com/doi/10.1177/08968608221080586What’s new with the 2022 update of the ISPD peritonitis guidelines? Peritoneal dialysis (PD)-associated peritonitis is a serious complication of PD and prevention and treatment of such is important in reducing patient morbidity and mortality.Thu, 03 Sep 2026 17:52:00 GMThttps://anzsnevents.com/wp-content/uploads/2023/10/Template-UOA-Mark-Marshall.pdfChow et al. ISPD Catheter-related Infection Recommendations: 2023 Update.Fri, 04 Sep 2026 14:16:00 GMThttps://pubmed.ncbi.nlm.nih.gov/35264029/The ISPD 2022 updated recommendations have revised and clarified definitions for refractory peritonitis, relapsing peritonitis, peritonitis-associated catheter removal, PD-associated haemodialysis transfer, peritonitis-associated death and peritonitis-associated hospitalisation.Wed, 02 Sep 2026 18:36:00 GMThttps://www.annualdialysisconference.org/wp-content/uploads/2019/07/RIVARA_2022-ISPD-Peritonitis-Guidelines.pdfAvoiding H2 blockers to prevent peritonitis “We suggest that avoiding or limiting the use of histamine-2 receptor antagonists may prevent enteric peritonitis (2C).Fri, 04 Sep 2026 02:49:00 GMThttps://journals.sagepub.com/doi/abs/10.1177/08968608221080586New recommendations regarding management of modifiable peritonitis risk factors like domestic pets, hypokalaemia and histamine-2 receptor antagonists are highlighted.Tue, 01 Sep 2026 19:35:00 GMThttps://www.bcrenal.ca/resource-gallery/Documents/BCKD23_ISPD%20Updates_Zeng_Yan.pdfWe suggest that avoiding or limiting the use of histamine-2 receptor antagonists may prevent enteric peritonitis [2C]. Supplementing K to 4-5 resulted in longer time to first peritonitis by 90 days, lower HR of peritonitis (0.47), and greater of proportion of peritonitis free patients (29% vs 15%).Fri, 28 Aug 2026 10:14:00 GMThttps://pubmed.ncbi.nlm.nih.gov/37232412/Peritoneal dialysis (PD) catheter-related infections are important risk factors for catheter loss and peritonitis. The 2023 updated recommendations have revised and clarified definitions and classifications of exit site infection and tunnel infection.Thu, 03 Sep 2026 22:17:00 GMThttps://www.scribd.com/document/878727581/li-et-al-2022-ispd-peritonitis-guideline-recommendations-2022-update-on-prevention-and-treatmentThe ISPD 2022 guidelines provide updated recommendations for the prevention and treatment of peritoneal dialysis (PD)-associated peritonitis, emphasizing the importance of clear definitions and management strategies to reduce patient morbidity and mortality.Fri, 04 Sep 2026 04:43:00 GMT